Syncom Healthcare IPO Basis of Allotment

SYNCOM HEALTHCARE LIMITED

(The Company was originally incorporated as Syncom Healthcare Limited on July 29, 2002 by Registrar of Companies, Maharashtra. Mumbai vide CIN:L51397MH2002PLC136652. The Certificate for Commencement of business was granted on August 2, 2002)
Registered Office: 221, Vyapar Bhawan, P.D.Mello Road, Mumbai-400009, Telefax: +91-22-23725193
Corporate Office: 'SYNCOM HOUSE', 293/2, Niranjanpur, Dewas Naka, A. B. Road. Indore . 452 010, Tel: +91-731-2577471-73,
Fax: +91-731-2577470, Email: ipo@syncomhealthcare.com, Website; www.syncomhealthcare.com
Contact person: Mr. Jagdish Chandra Paliwal, Vice President (Finance), Company Secretary & Compliance Officer.

BASIS OF ALLOTMENT

PUBLIC ISSUE OF 75,00,000 EQUITY SHARES OF Rs.10 EACH FOR CASH AT A PRICE OF Rs.75 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF Rs.65 PER EQUITY SHARE) AGGREGATING Rs.5625.00 LACS (HEREINAFTER REFERRED TO AS THE 'ISSUE') BY SYNCOM HEALTHCARE LIMITED ('THE COMPANY' OR 'ISSUER' OR 'SHL'). THE ISSUE WILL CONSTITUTE 42.86 % OF THE FULLY DILUTED POST ISSUE PAID UP CAPITAL OF THE COMPANY.

ISSUE PRICE:RS.75 PER EQUITY SHARE OF FACE VALUE RS.10 EACH THE ISSUE PRICE IS 7.5 TIMES OF THE FACE VALUE

The Issue was made through the 100% Book Building Process wherein upto 50% of the Issue to Ihe public shall be allocated on a proportionate basis lo Qualified Institutional Buyers, out of which 5% of the QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all Qualifed Institutional Buyers, including Mutual Funds, subject to valid Bids being received at or above Issue Price. Further, at least 15% of the Issue to the public shall be available for allocation on a proportionate basis to Non -Institutional Bidders and at least 35% of the Issue lo the public shall be available for allocation on a proportionate basis to Retail Individual Bidders, subject to valid Bids being received at or above the Issue Price. The Issue received 17,859 applications for 3,64,71,240 equity shares resulting in 4.8628 times subscription. The details of the applications received in the Issue from Qualified Institutional Buyers, Non-Institutional, Retail Individual Investor and Employee categories are as under: (Before technical rejections)

Final Demand
A summary of the final demand as per BSE and NSE as on the Bid/Issue Closing date at different bid prices is as under:

The Basis of Allocation was finalized in consultation with the Designated Stock Exchange, being the Bombay Stock Exchange Limited ('BSE') on February 5,2010.

A. Allocation to Retail Individual Investors (After Tachnical Rejections)
The Basis of Allocation to the Retail Individual Investors, who have bid at cut-off or at the Issue Price of Rs. 75 per Equity Share, was finalized in consultation with BSE. The category was over subscribed 5.90 times. As per the Red Herring Prospectus, the spill over portion from QIB Category was 36,456 equity shares. The total number of shares allotted in this category is 26,61,456 Equity Shares to 13,843 successful applicants. The category-wise details of the Basis of Allocation are as under:

B. Allocation to Non Institutional investors(AfterTechnical Rejections)
The Basis of Allocation to the Non Institutional Investors, who have bid at the Issue Price of Rs. 75 per Equity Share, was finalized in consultation with BSE. The category was over subscribed 14.86 times. As per the Red Herring Prospectus, the spill over portion from QIB Category to the extent of 15,624 equity shares The total number of shares allotted in this category is 11,40,624 Equity Shares to 77 successful applicants. The category-wise details of the Basis of Allocation (Sample) are as under:

C. Allocation to QIB
Allocation to OIBs has been done on a proportionate basis in consultation with BSE. No Mutual Funds applications was received in the Issue. The unsubscribed portion of QIB category i.e. 52,080 equity shares has been added to the Retail Category (36,456) and Non Institutional Investors (15,624)in the ratio of 70:30.

The Board of Directors of the company at its Meeting held at Indore on February 6,2010 has approved the basis of allocation of shares of the Issue and has allotted the shares to various successful applicants.
The CAN-cum-Refund Orders and allotment advice cum ECS/RTGS/NEFT/Dlrect Credit Intimation have Been dispatched on Februarys, 2010 to the address of the investors as registered with the depositories. In case the same is not received within ten days, investors may contact at the address given below. Instructions to ASBA banks to transfer funds related to equity shares allocated, if any, and unblock the remaining amount have been given on February 6, 2010. The Company has filed listing application with Bombay Stock Exchange Limited and National Stock Exchange of India Limited on February 9.2010. The Refund Orders have been over-printed with the Bank Mandate details as registered, if any,with the depositories. The shares allocated to successful applicants have been credited to their beneficiary accounts subject to validation of the account details with the depositories concerned The company is taking steps to get the equity shares admitted for trading on Bombay Stock Exchange Limited and the National Stock Exchange of India Limited within seven working days from the date of approval of the basis of allocation.
Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them in the prospectus dated February 2,2010 ('Prospectus')

INVESTORS PLEASE NOTE
This details of the allocation made have been hosted on the website of Registrar to the Issue, Link Intime India Private Limited at www.linkintime.co.in
All future correspondence in this regard may kindly be addressed to the Registrar to the issue quoting full name of the First / Sole applicant, Serial number of the Bid-cum-appllcation from, number of shares bid for, name of the Member of the Syndicate and place where the bid was submitted any payment details at the address givan below:

Link Intime India Private Limited C-13, Pannalal Silk Mills Compound, LBS Marg, Bhandup (West), Mumbai 400078. Tel:+91-22-25960320, Fax:+91-22-25960329 E-mail: shl.ipo@linkintime.co.in Website: www.linkintime.co.in Contact Person: Mr. Chetan shinde.

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER JTHEMARKETPRICEOFTHEEQUITYSHAREONLISTINGORTHEBUSINESSPROSPECTS OF SYNCOM HEALTHCARE LIMITED.